BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 70364)

  • 1. Failure of T cells specific for strong histocompatibility antigens to cooperate with B cells for a humoral response.
    Dennert G; De Rose M; Allen RS
    Eur J Immunol; 1977 Jul; 7(7):487-92. PubMed ID: 70364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces.
    Coutinho A; Augustin AA
    Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuously proliferating T killer cells specific for H-2b targets: selection and characterization.
    Dennert G; De Rose M
    J Immunol; 1976 Jun; 116(6):1601-6. PubMed ID: 58039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
    Budhecha S; Hamilton BL
    J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population.
    DeKruyff R; Clayberger C; Cantor H; Dorf ME
    J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell tolerization in vitro: modulation of helper and suppressor cell activities.
    Bleux C; Liacopoulos P; Couderc J; Kanellopoulos-Langevin C
    J Immunol; 1987 Jul; 139(2):338-45. PubMed ID: 2439586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The humoral response of mouse spleen cells to two types of sheep erythrocytes. II. Evidence for gene expression in the B lymphocyte.
    McCarthy MM; Dutton RW
    J Immunol; 1975 Nov; 115(5):1322-6. PubMed ID: 1080778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a T suppressor cell-inducing antigenic determinant shared by ADJ-PC-5 plasmacytoma and syngeneic BALB/c spleen cells.
    Kloke O; Haubeck HD; Kölsch E
    Eur J Immunol; 1986 Jun; 16(6):659-64. PubMed ID: 2424769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the immune response to fixed antigens. II. Optimal conditions for inducing and eliciting helper function by fixed antigens and the mechanism responsible for this effect.
    Naor D; Kahan M
    Isr J Med Sci; 1977 Jun; 13(6):561-76. PubMed ID: 328450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell interactions between histoincompatible T an B lymphocytes. IX. The failure of histoincompatible cells is not due to suppression and cannot be circumvented by carrier-priming T cells with allogeneic macrophages.
    Katz DH; Chiorazzi N; McDonald J; Katz LR
    J Immunol; 1976 Nov; 117(5 Pt.2):1853-9. PubMed ID: 62793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of organ differences in peripheral B cell populations through the use of deficient fetal bovine serum.
    Campbell SM; Kagnoff MF; Watson J
    J Immunol; 1975 Mar; 114(3):992-6. PubMed ID: 803537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-forming cells with specificity for syngeneic and allogeneic (thymocyte) tissue antigens following lipopolysaccharide mitogenic stimulation.
    McHugh YH; Bonavida B
    Transplant Proc; 1977 Mar; 9(1):1205-9. PubMed ID: 68566
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of serologically detectable histocompatibility antigens in the induction and effector step of cell-mediated lysis.
    Dennert G; Hyman R
    Eur J Immunol; 1977 May; 7(5):251-7. PubMed ID: 141372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.